LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 95.66 | 27.76 | 6154 | 6712 | 0.9168 | 0.9782 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 95.66 | 27.76 | 7918 | 6712 | 1.1796 | 1.0422 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 1.95 | 27.76 | 2 | 225 | 0.0089 | -0.5815 | MN20160318_Q01 | E20 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 1.95 | 27.76 | 444 | 225 | 1.9721 | 1.5043 | MN20160318_Q01 | E20 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | H05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 1.95 | 27.76 | 553 | 225 | 2.4562 | 1.6932 | MN20160318_Q01 | H05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | I21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 1.95 | 27.76 | 642 | 225 | 2.8515 | 1.8296 | MN20160318_Q01 | I21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 3.66 | 27.76 | 3 | 283 | 0.0106 | -0.4848 | MN20160318_Q01 | E20 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 3.66 | 27.76 | 589 | 283 | 2.0745 | 1.4860 | MN20160318_Q01 | E20 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | H05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 3.66 | 27.76 | 612 | 283 | 2.1555 | 1.5146 | MN20160318_Q01 | H05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | I21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 3.66 | 27.76 | 715 | 283 | 2.5182 | 1.6339 | MN20160318_Q01 | I21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 5.36 | 27.76 | 6 | 320 | 0.0187 | -0.3522 | MN20160318_Q01 | E20 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 5.36 | 27.76 | 661 | 320 | 2.0633 | 1.4557 | MN20160318_Q01 | E20 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | H05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 5.36 | 27.76 | 676 | 320 | 2.1101 | 1.4714 | MN20160318_Q01 | H05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | I21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 5.36 | 27.76 | 788 | 320 | 2.4598 | 1.5811 | MN20160318_Q01 | I21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | E20 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 7.06 | 27.76 | 718 | 360 | 1.9944 | 1.4106 | MN20160318_Q01 | E20 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | H05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 7.06 | 27.76 | 740 | 360 | 2.0556 | 1.4304 | MN20160318_Q01 | H05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | I21 |